Evidence map›Paper›PMID 39139223›Full record

ArticleJournal of the Canadian Association of Gastroenterology2024

Canadian colorectal cancer screening programs: How do they measure up using the International Agency for Research on Cancer criteria for organized screening?

Cindy C Y Law, Li Zhang, André L Carvalho, Linda Rabeneck, Alan N Barkun, Anja Nied-Kutterer, David Armstrong, Clarence K Wong, Diane Lamothe, Donald MacIntosh and 27 more

Abstract read
In one paragraph

Article in Journal of the Canadian Association of Gastroenterology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors.

Cindy C Y LawDivision of Gastroenterology & Hepatology, University of Toronto, Toronto M5G 1V7, Canada.
Li ZhangInternational Agency for Research on Cancer (World Health Organization), Lyon 69007, France.
André L CarvalhoInternational Agency for Research on Cancer (World Health Organization), Lyon 69007, France.
Linda RabeneckDalla Lana School of Public Health and Department of Medicine, University of Toronto, Toronto M5T 3M7, Canada.
Alan N BarkunDivision of Gastroenterology & Hepatology, McGill University, Montreal H3A 0G4, Canada.
Anja Nied-KuttererHealth PEI, Charlottetown C1A 7N8, Canada.
David ArmstrongDivision of Gastroenterology & Hepatology, McMaster University, Hamilton L8S 4L8, Canada.ORCID https://orcid.org/0000-0003-2487-1479
Clarence K WongDivision of Gastroenterology, University of Alberta, Edmonton T6G 2R3, Canada.
Diane LamotheYukon Government, Whitehorse Y1A 2C6, Canada.
Donald MacIntoshDivision of Gastroenterology, Dalhousie University, Halifax B3H 4R2, Canada.
Catherine DubéDivision of Gastroenterology, University of Ottawa, Ottawa K1H 8M5, Canada.
Eileen KilfoilNova Scotia Health Authority, Halifax B3S 0H6, Canada.
Jennifer TelfordDivision of Gastroenterology, University of British Columbia, Vancouver V5Z 1M9, Canada.
Nancy N BaxterSchool of Population and Global Health, University of Melbourne, Melbourne 3053, Australia.
Eshwar KumarGovernment of New Brunswick, Fredericton E3B 5H1, Canada.
Harminder SinghDivision of Gastroenterology, University of Manitoba, Winnipeg R3A 1R9, Canada.ORCID https://orcid.org/0000-0002-9354-2356
Jerry McGrathDivision of Gastroenterology, Memorial University, St John's, A1B 3V6, Canada.
Laura CoulterCancerCare Manitoba, Winnipeg R3E 0V9, Canada.
Daniel SadowskiDivision of Gastroenterology, University of Alberta, Edmonton T6G 2R3, Canada.
Karen EfthimiouSaskatchewan Health Authority, Regina S7K 0M7, Canada.
Hendrik DuPlessisUniversity of Saskatchewan, Saskatoon S7N 5A2, Canada.
Kelly BunzelukCancerCare Manitoba, Winnipeg R3E 0V9, Canada.
Laura GentileBC Cancer Agency, Vancouver V5Z 4E6, Canada.
Marie-Hélène GuertinInstitut National de Santé Publique du Québec, Québec G1V 5B3, Canada.
Bronwen R McCurdyCancerCare Ontario, Toronto M5G 2L3, Canada.
Michael KohleGovernment of Nunavut, Iqaluit X0A 0R0, Canada.
Michael StewartDivision of Gastroenterology, Dalhousie University, Halifax B3H 4R2, Canada.
Ross StimpsonCancerCare Manitoba, Winnipeg R3E 0V9, Canada.
Scott AntleEastern Health Cancer Care, St. John's, A1B 3V6, Canada.
Shelley PolosSaskatchewan Cancer Agency, Regina S4W 0G3, Canada.
Steven J HeitmanDivision of Gastroenterology & Hepatology, University of Calgary, Calgary T2N 4Z6, Canada.
Tong ZhuSaskatchewan Cancer Agency, Regina S4W 0G3, Canada.
Simbi EbenuwahCancerCare Ontario, Toronto M5G 2L3, Canada.
Judy KosloskiSaskatchewan Cancer Agency, Regina S4W 0G3, Canada.
Melissa MokFaculty of Medicine, University of Calgary, Calgary T2N 4N1, Canada.
Partha BasuInternational Agency for Research on Cancer (World Health Organization), Lyon 69007, France.
Jill TinmouthDivision of Gastroenterology & Hepatology, University of Toronto, Toronto M5G 1V7, Canada.ORCID https://orcid.org/0000-0002-0264-2176

Funding

World Health Organization 001
6 · The paper itself

Abstract

Background: Canada has one of the highest incidences of colorectal cancer (CRC) worldwide. CRC screening improves CRC outcomes and is cost-effective. This study compares Canadian CRC screening programs using essential elements of an organized screening program outlined by the International Agency for Research on Cancer (IARC). Methods: We collaborated with the Cancer Screening in 5 continents (CanScreen5) program, an initiative of IARC. Standardized data collection forms were sent to representatives of provincial and territorial CRC screening programs. Twenty-five questions were selected to reflect IARC's essential elements of an organized screening program. We performed a qualitative analysis of Canada's CRC screening programs and compared programs within Canada and internationally. Results: CRC screening programs exist in 10 provinces and 2 territories. None of the programs in Canada met all the essential criteria of an organized screening program outlined by IARC. Three programs do not send invitations to participate in screening. Among those that do, 4 programs do not include a stool test kit in the invitations. While all provinces met the essential elements for leadership, governance, finance, and access to essential services, there was more heterogeneity in the domains of service delivery as well as information systems and quality assurance. Conclusions: There is considerable heterogeneity in the design of CRC screening programs in Canada and worldwide. Programs should strive to meet all the essential IARC criteria for organized screening if local resources allow, such as issuing invitations and implementing systems to track and compare outcomes to maximize screening program quality, effectiveness, and impact.

Indexed as

Colorectal cancerorganizedscreening

Identifiers

PMID39139223
PMCPMC11317627

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.